TSHR and hyperthyroidism: It is hypothesized that the increase in ROS can cause dual actions, as follows: (a) an increased release of autoantigens and production of TSH-R autoantibodies (TRAb), and (b) orbital tissue damage that contributes to the clinical manifestations of hyperthyroidism.